Allan M. Burkman

641 total citations
45 papers, 515 citations indexed

About

Allan M. Burkman is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Allan M. Burkman has authored 45 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Organic Chemistry and 8 papers in Pharmacology. Recurrent topics in Allan M. Burkman's work include Antibiotics Pharmacokinetics and Efficacy (5 papers), Chemical synthesis and alkaloids (5 papers) and Receptor Mechanisms and Signaling (4 papers). Allan M. Burkman is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (5 papers), Chemical synthesis and alkaloids (5 papers) and Receptor Mechanisms and Signaling (4 papers). Allan M. Burkman collaborates with scholars based in United States. Allan M. Burkman's co-authors include Theodore D. Sokoloski, Richard H. Fertel, Richard A. Keith, Joseph G. Cannon, Robert E. Notari, Lei Wu, Ralph W. Morris, Dennis B. McKay, Marvin F. Blanford and K Bachmann and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Urology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Allan M. Burkman

43 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allan M. Burkman United States 14 161 139 84 82 78 45 515
Joseph J. McPhillips United States 15 219 1.4× 117 0.8× 63 0.8× 36 0.4× 164 2.1× 25 613
Alan A. Rubin United States 10 128 0.8× 65 0.5× 68 0.8× 67 0.8× 35 0.4× 23 473
Ralf G. Rahwan United States 17 342 2.1× 182 1.3× 168 2.0× 103 1.3× 179 2.3× 65 774
John F. Waterfall United Kingdom 14 307 1.9× 124 0.9× 84 1.0× 77 0.9× 136 1.7× 34 585
Byron E. Leach United States 15 204 1.3× 147 1.1× 71 0.8× 59 0.7× 49 0.6× 23 795
G. Kuschinsky Germany 15 275 1.7× 77 0.6× 135 1.6× 50 0.6× 80 1.0× 99 751
Eskil Hansson Sweden 13 190 1.2× 75 0.5× 28 0.3× 57 0.7× 102 1.3× 24 578
Kanoo Hosoki Japan 11 174 1.1× 91 0.7× 93 1.1× 25 0.3× 55 0.7× 64 481
A. Pinelli Italy 12 132 0.8× 66 0.5× 59 0.7× 25 0.3× 80 1.0× 66 434
Horacio Vidrio Mexico 14 163 1.0× 121 0.9× 59 0.7× 86 1.0× 90 1.2× 63 588

Countries citing papers authored by Allan M. Burkman

Since Specialization
Citations

This map shows the geographic impact of Allan M. Burkman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allan M. Burkman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allan M. Burkman more than expected).

Fields of papers citing papers by Allan M. Burkman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allan M. Burkman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allan M. Burkman. The network helps show where Allan M. Burkman may publish in the future.

Co-authorship network of co-authors of Allan M. Burkman

This figure shows the co-authorship network connecting the top 25 collaborators of Allan M. Burkman. A scholar is included among the top collaborators of Allan M. Burkman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allan M. Burkman. Allan M. Burkman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Konkar, Anish, et al.. (1996). Pharmacological activities of trimetoquinol and 1-benzyl halogen-substituted analogues on rat β-adrenoceptor subtypes. European Journal of Pharmacology. 305(1-3). 63–71. 6 indexed citations
2.
Lee, Ming‐Chieh, et al.. (1995). Gangliosides have a bimodal effect on DNA synthesis in U‐1242 MG human glioma cells. Journal of Neuroscience Research. 41(4). 491–500. 5 indexed citations
3.
Burkman, Allan M., et al.. (1994). Comparison of the effects of antimitotic drugs on α-tubulin mRNA, microtubules and nicotinic receptor-mediated catecholamine secretion in adrenal chromaffin cells in culture. General Pharmacology The Vascular System. 25(3). 439–446. 1 indexed citations
4.
McKay, Dennis B. & Allan M. Burkman. (1993). Nicotinic and Nonnicotinic Receptor-Mediated Actions of Vinblastine. Experimental Biology and Medicine. 203(3). 372–376. 13 indexed citations
5.
Himori, Noriko, et al.. (1990). Ischaemically induced alterations in electrical activity and mechanical performance of isolated blood perfused canine myocardial preparations. Cardiovascular Research. 24(10). 786–792. 4 indexed citations
6.
Burkman, Allan M., et al.. (1988). Inhibition of Prolactin Release from Anterior Pituitary Lactotrophs in Culture by Sulfur-Containing Analogs of Dopamine. Experimental Biology and Medicine. 188(1). 87–91. 1 indexed citations
7.
Wu, Chun-Yi, Theodore D. Sokoloski, Lei Wu, & Allan M. Burkman. (1983). Interaction of Nitroglycerin With Human Blood Components. Journal of Pharmaceutical Sciences. 72(4). 335–338. 16 indexed citations
8.
Keith, Richard A., Allan M. Burkman, Theodore D. Sokoloski, & Richard H. Fertel. (1982). Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle.. Journal of Pharmacology and Experimental Therapeutics. 221(3). 525–531. 95 indexed citations
9.
Burkman, Allan M., et al.. (1982). Haloperidol Causes Irreversible Damage to Rat Anterior Pituitary Lactotropes in Culture. The Journal of Urology. 128(5). 1138–1138. 3 indexed citations
10.
Burkman, Allan M.. (1982). Assessment of emetic and antiemetic activity. Journal of Pharmacological Methods. 8(3). 165–171. 4 indexed citations
11.
Bachmann, K & Allan M. Burkman. (1975). Topical application of a chlordane-containing ectoparasiticide: effect on the plasma half-life of warfarin in dogs. Laboratory Animals. 9(2). 135–137. 1 indexed citations
12.
Burkman, Allan M.. (1973). Biological activity of apomorphine fragments: Dissociation of emetic and stereotypical effects. Neuropharmacology. 12(1). 83–85. 10 indexed citations
13.
Burkman, Allan M., et al.. (1970). New Method for Assaying Antiapomorphine Activity in Pigeons. Journal of Pharmaceutical Sciences. 59(12). 1757–1759. 2 indexed citations
14.
Burkman, Allan M., et al.. (1969). Centrally Acting Emetics. III. Derivatives of beta-Naphthylamine. Journal of Medicinal Chemistry. 12(3). 487–490. 12 indexed citations
15.
Wiley, Michael R., et al.. (1968). Inhibition of Liver-Derived Monoamine Oxidase by Several Isopropyl Hydrazides. Journal of Pharmaceutical Sciences. 57(11). 2011–2012. 2 indexed citations
16.
Cannon, Joseph G., et al.. (1968). Centrally acting emetics. II. Norapomorphine and derivatives. Journal of Medicinal Chemistry. 11(5). 977–981. 30 indexed citations
17.
Burkman, Allan M.. (1965). Some Kinetic and Thermodynamic Characteristics of Apomorphine Degradation. Journal of Pharmaceutical Sciences. 54(2). 325–326. 19 indexed citations
18.
Burkman, Allan M.. (1961). Antagonism of Apomorphine by Chlorinated Phenothiazines. Journal of Pharmaceutical Sciences. 50(2). 156–160. 7 indexed citations
19.
Morris, Ralph W. & Allan M. Burkman. (1960). Current Topics in Pharmacology. American Journal of Health-System Pharmacy. 17(3). 148–152. 16 indexed citations
20.
Burkman, Allan M., A. Tye, & John W. Nelson. (1957). Antiemetics in the Pigeon**College of Pharmacy, Ohio State University, Columbus 10. Journal of the American Pharmaceutical Association (Scientific ed ). 46(2). 140–144. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph J. McPhillips Breakdown of academic impact, for papers by Alan A. Rubin Breakdown of academic impact, for papers by Ralf G. Rahwan Breakdown of academic impact, for papers by John F. Waterfall Breakdown of academic impact, for papers by Byron E. Leach Breakdown of academic impact, for papers by G. Kuschinsky Breakdown of academic impact, for papers by Eskil Hansson Breakdown of academic impact, for papers by Kanoo Hosoki Breakdown of academic impact, for papers by A. Pinelli Breakdown of academic impact, for papers by Horacio Vidrio
Rankless by CCL
2026